gvtcx

PHE_Scientific Provision for purchase of the TaqMan SARS-CoV-2 Mutation panel

Public Health England Published 28 Apr 2021 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£150,000
Statuscomplete
Category (CPV) 33696500
Deadline27 Apr 2021
Contract start28 Apr 2021
Contract end27 Oct 2021
Procedureselective
SME suitableYes
OCIDocds-b5fd17-1158ed84-378d-47bd-a532-cc4fb67f84fb

Award

SupplierValueDateStatus
LIFE TECHNOLOGIES LIMITED £150,000 26 Apr 2021 active

description

PHE has awarded an interim contract to Life Technologies Ltd (Thermo Fisher Scientific) for the provision of purchase of TaqMan SARS-CoV-2 Mutation panel to facilitate in the identification and discrimination of the SARS CcV 2 variants VOC20DEC01, VOC20DEC02 and VOC21JAN02 .

The roll out of these panels will help to increase the national coverage of the identification of SARS-CoV-2 across the country.

It is a PHEwide 6 month contract with an option to extend for a further 6 months.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
28 Apr 2021 Award (award) · dc07cfdf-caaf-43d3-8928-1e54f830f029-432418

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.